Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Worcester, Massachusetts 01655


Purpose:

Japanese postmenopausal women in Japan have about one ninth the rate of American postmenopausal women. Rates of breast cancer double even after just ten years among Japanese women who migrate to the US. Diet is thought to be an important factor, and the investigators were interested in whether dietary seaweed, with and without soy supplements, could influence known biomarkers of breast cancer risk in American women.


Study summary:

33 healthy postmenopausal women were randomized to 6 wk seaweed then 1 wk seaweed plus soy or 6 wk placebo then 1 wk placebo plus soy. Blood and urine samples were collected at the end of each treatment period and analyzed for estrogen, homocysteine, antioxidants, insulin-like growth factors and thyroid hormones. Urine was analyzed for phytoestrogens and iodine.


Criteria:

Inclusion Criteria: - Postmenopausal (self-reported cessation of menstruation 1 y prior to enrollment) - If breast cancer survivor, all therapy completed at least 6 months prior to enrollment - Agreed to eat their normal diet, avoiding seaweeds and phytoestrogen-rich foods, - Restricting alcoholic intake to #2 drinks (24 g alcohol)/wk -Continuing habitual intake of vitamins, supplements, and medications during the study. - Exclusion Criteria: - No allergies to seaweed, soy, shellfish, or iodine - No current use of tobacco; - No thyroid dysfunction or treatment within the previous 5 y; - Negative thyroid peroxidase antibodies as determined by screening; - No hormone replacement therapy or for breast cancer survivors, no chemotherapy or radiation treatments within the preceding 6 mo - No history of cancer (other than breast cancer) - No current gastrointestinal disorders or diabetes; omnivorous eating habits, including meat and dairy products at least twice/wk - No oral antibiotics, iodine containing medications, or corticosteroids treatment within the previous 3 mo.


NCT ID:

NCT01204957


Primary Contact:

Study Director
Jane Teas, Ph.D.
University of South Carolina


Backup Contact:

N/A


Location Contact:

Worcester, Massachusetts 01655
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.